Novartis India Ltd.
Snapshot View

View in App

Prices View details >>

641.00 +27.45 ▲4.5%

31 January 2023, 04:01:00 PM
Volume: 1,189

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.novartis.in
Market Cap 1,575.52 Cr.
Enterprise Value(EV) 1,010.38 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 21.75 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 29.33 Trailing Twelve Months Ending 2022-09
Industry PE 32.54 Trailing Twelve Months Ending 2022-09
Book Value / Share 299.19 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.13 Calculated using Price: 638.10
Dividend Yield 1.57 Period Ending 2022-03
No. of Shares Subscribed 2.47 Cr. 24,690,797 Shares
FaceValue 5
Company Profile
Novartis has been in India since 1947. The Group operates in India through four entities namely Novartis India Limited, listed on the Mumbai Stock Exchange, Novartis Healthcare Private Limited, Sandoz Private Limited and Chiron-Behring Vaccine Private Limited. In India Novartis have a presence in pharmaceuticals, generics (pharmaceutical products that are off patent), Vaccines, OTC (over-the-counter medicines), eyecare and Animal Health.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.47%
1 Week
+0.12%
1 Month
-5.04%
3 Month
-5.74%
6 Month
-11.31%
1 Year
-13.43%
2 Year
-2.07%
5 Year
+0.23%
10 Year
-0.56%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.59 8.06 18.01 5.38 9.40 6.89 1.36 2.91 -0.53
Return on Capital Employed (%) 9.69 9.52 24.77 8.75 19.72 11.70 4.73 6.67 0.14
Return on Assets (%) 4.98 3.89 11.38 3.27 3.75 2.51 0.62 1.22 -0.18

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 961 1,002 1,194 920 734 759 721 711 692 739
Non Curr. Liab. 586 697 26 828 898 891 99 1,131 1,000 32
Curr. Liab. 459 362 204 323 482 367 417 357 334 204
Minority Int.
Equity & Liab. 2,006 2,060 1,425 2,070 2,113 2,018 1,237 2,199 2,026 974
Non Curr. Assets 698 846 161 959 1,009 1,029 240 1,277 1,199 224
Curr. Assets 1,308 1,215 1,264 1,111 1,104 989 997 922 827 750
Misc. Exp. not W/O
Total Assets 2,006 2,060 1,425 2,070 2,113 2,018 1,237 2,199 2,026 974

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 862 873 690 656 564 491 438 381 400 420
Other Income 97 112 245 72 174 78 36 34 35 54
Total Income 959 985 934 728 738 569 475 416 435 473
Total Expenditure -866 -881 -659 -632 -572 -479 -427 -356 -374 -359
PBIDT 94 104 275 96 166 91 48 60 60 114
Interest 0 0 0 -1 -6 -2 -6 -8 -5 -3
Depreciation -4 -4 -3 -4 -3 -3 -13 -12 -10 -7
Taxation 9 -14 -73 -35 -79 -34 -19 -19 0 -1
Exceptional Items -6 -50 -50
PAT 99 79 198 57 78 52 10 21 -4 54
Adjusted EPS 31 25 62 20 32 21 4 8 -2 22

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 7 -5 -60 57 -41 161 -194 -23 -69 39
Cash Fr. Inv. -16 22 719 -630 424 69 274 56 95 87
Cash Fr. Finan. -37 -38 -38 -39 -332 -268 -30 -41 -37 -36
Net Change -46 -20 622 -612 51 -38 50 -9 -11 90
Cash & Cash Eqvt 36 15 637 25 76 38 88 79 68 158

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68
Public 29.32 29.32 29.32 29.32 29.32 29.32 29.32 29.32 29.32
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 30 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Tue, 17 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Fri, 13 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Technical Scans View Details >>

Tue, 31 Jan 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,331.17 1,034.50 -1.6%
Divi's Laboratories Ltd. 88,067.87 3,315.30 -1.5%
Cipla Ltd. 82,086.54 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. 72,004.82 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. 61,188.28 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. 51,492.78 1,521.45 -1.7%
Abbott India Ltd. 44,288.65 20,785.15 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.96 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.43 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 31.11 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.72 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.88 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.96 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 50.23 20,785.15 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.68 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.26 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 3.62 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.26 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.22 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.08 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 16.32 20,785.15 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 0.00 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,785.15 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 798.70 20,785.15 -0.9%

FAQ's On Novartis India Ltd.

What is Novartis share price?
Can I buy Novartis shares now?
What is the Dividend Yield of Novartis?
What is the Market Cap of Novartis?
What are the key metrics to analyse Novartis?
What is the 52 Week High and Low of Novartis?
What is the trend of Novartis share price?